BLIS Technologies Ltd
NZX:BLT

Watchlist Manager
BLIS Technologies Ltd Logo
BLIS Technologies Ltd
NZX:BLT
Watchlist
Price: 0.017 NZD -5.56% Market Closed
Market Cap: NZ$21.7m

Relative Value

The Relative Value of one BLT stock under the Base Case scenario is hidden NZD. Compared to the current market price of 0.017 NZD, BLIS Technologies Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLT Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

BLT Competitors Multiples
BLIS Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
BLIS Technologies Ltd
NZX:BLT
21.7m NZD 1.5 21.2 11.8 11.8
US
Eli Lilly and Co
NYSE:LLY
1.1T USD 17.7 57 38.2 41
US
Johnson & Johnson
NYSE:JNJ
564.7B USD 6 21.1 14.7 18
CH
Roche Holding AG
SIX:ROG
282.5B CHF 4.6 30 12.7 14.8
US
Merck & Co Inc
NYSE:MRK
294.9B USD 4.5 16.2 10.1 11.8
CH
Novartis AG
SIX:NOVN
226B CHF 5.2 20.2 12.7 16.4
UK
AstraZeneca PLC
LSE:AZN
212.5B GBP 5.1 31.4 15 21.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.3 13 9 10.5
US
Pfizer Inc
NYSE:PFE
153.2B USD 2.4 19.7 7.4 9.8
FR
Sanofi SA
PAR:SAN
98.3B EUR 1.7 8.2 7.7 7.7
P/E Multiple
Earnings Growth PEG
NZ
BLIS Technologies Ltd
NZX:BLT
Average P/E: 23.8
21.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
57
54%
1.1
US
Johnson & Johnson
NYSE:JNJ
21.1
6%
3.5
CH
Roche Holding AG
SIX:ROG
30
29%
1
US
Merck & Co Inc
NYSE:MRK
16.2
14%
1.2
CH
Novartis AG
SIX:NOVN
20.2
17%
1.2
UK
AstraZeneca PLC
LSE:AZN
31.4
38%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13
2%
6.5
US
Pfizer Inc
NYSE:PFE
19.7
26%
0.8
FR
Sanofi SA
PAR:SAN
8.2
1%
8.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NZ
BLIS Technologies Ltd
NZX:BLT
Average EV/EBITDA: 42.9
11.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
34%
1.1
US
Johnson & Johnson
NYSE:JNJ
14.7
2%
7.3
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
US
Merck & Co Inc
NYSE:MRK
10.1
7%
1.4
CH
Novartis AG
SIX:NOVN
12.7
6%
2.1
UK
AstraZeneca PLC
LSE:AZN
15
10%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9
1%
9
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
FR
Sanofi SA
PAR:SAN
7.7
8%
1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NZ
BLIS Technologies Ltd
NZX:BLT
Average EV/EBIT: 90.8
11.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
41
37%
1.1
US
Johnson & Johnson
NYSE:JNJ
18
6%
3
CH
Roche Holding AG
SIX:ROG
14.8
6%
2.5
US
Merck & Co Inc
NYSE:MRK
11.8
6%
2
CH
Novartis AG
SIX:NOVN
16.4
12%
1.4
UK
AstraZeneca PLC
LSE:AZN
21.9
23%
1
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.5
0%
N/A
US
Pfizer Inc
NYSE:PFE
9.8
-1%
N/A
FR
Sanofi SA
PAR:SAN
7.7
6%
1.3